Identification of neutral tumor evolution across cancer types

Nature Genetics
Marc J WilliamsAndrea Sottoriva

Abstract

Despite extraordinary efforts to profile cancer genomes, interpreting the vast amount of genomic data in the light of cancer evolution remains challenging. Here we demonstrate that neutral tumor evolution results in a power-law distribution of the mutant allele frequencies reported by next-generation sequencing of tumor bulk samples. We find that the neutral power law fits with high precision 323 of 904 cancers from 14 types and from different cohorts. In malignancies identified as evolving neutrally, all clonal selection seemingly occurred before the onset of cancer growth and not in later-arising subclones, resulting in numerous passenger mutations that are responsible for intratumoral heterogeneity. Reanalyzing cancer sequencing data within the neutral framework allowed the measurement, in each patient, of both the in vivo mutation rate and the order and timing of mutations. This result provides a new way to interpret existing cancer genomic data and to discriminate between functional and non-functional intratumoral heterogeneity.

References

Apr 1, 1996·Theoretical Population Biology·T Ohta, J H Gillespie
Jan 1, 1995·Annual Review of Genetics·P Donnelly, S Tavaré
Jul 27, 1987·Physical Review Letters·P BakK Wiesenfeld
Aug 11, 2004·Theoretical Population Biology·Richard Durrett, Jason Schweinsberg
May 12, 2006·Journal of Cellular Physiology·Henry H Q HengChristine J Ye
Mar 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Siân JonesSanford D Markowitz
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Sep 25, 2010·Proceedings of the National Academy of Sciences of the United States of America·Camille Stephan-Otto AttoliniFranziska Michor
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivana BozicMartin A Nowak
Mar 15, 2011·Nature·Nicholas NavinMichael Wigler
Apr 15, 2011·Cancer Prevention Research·Kathleen SprouffskeCarlo C Maley
Nov 10, 2011·PloS One·Yosef E MaruvkaNadav M Shnerb
Nov 10, 2011·PloS One·Moritz GerstungNiko Beerenwinkel
Jan 20, 2012·Nature·Mel Greaves, Carlo C Maley
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Apr 20, 2012·Nature Reviews. Cancer·Andriy MarusykKornelia Polyak
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium
Jul 20, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Aug 3, 2012·Nature·Gregory DriessensCédric Blanpain
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
Feb 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrea SottorivaSimon Tavaré
Mar 9, 2013·The Annals of Applied Probability : an Official Journal of the Institute of Mathematical Statistics·Rick Durrett
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Apr 30, 2013·Cell·Sylvan C BacaLevi A Garraway
Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·David A Kessler, Herbert Levine
Sep 21, 2013·Nature·Rebecca A BurrellCharles Swanton
Nov 23, 2013·Science·Louis VermeulenDouglas J Winton
Feb 11, 2014·Interface Focus·David Basanta, Alexander R A Anderson
Jul 2, 2014·Nature Reviews. Genetics·Thomas HelledaySerena Nik-Zainal
Oct 17, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F FaveroA C Eklund
Oct 29, 2014·BMC Systems Biology·Shuhao SunTianhai Tian
Feb 11, 2015·Nature Genetics·Andrea SottorivaChristina Curtis
Mar 19, 2015·The American Journal of Surgical Pathology·Moritz JesinghausWilko Weichert
Jul 15, 2015·Nature Reviews. Cancer·Doris P Tabassum, Kornelia Polyak
Jul 15, 2015·ELife·Wenying ShouFrances K Skinner
Dec 1, 2015·Nature Medicine·Noemi AndorCarlo C Maley
Jan 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F FaveroA C Eklund

❮ Previous
Next ❯

Citations

Sep 22, 2016·Molecular & Cellular Oncology·Marc J WilliamsAndrea Sottoriva
May 28, 2016·Genome Biology·Alexander Davis, Nicholas E Navin
Sep 30, 2016·Nature Genetics·Florian Markowetz
Jan 17, 2017·Nature Genetics·Alvin P Makohon-MooreChristine A Iacobuzio-Donahue
Feb 14, 2017·Nature Reviews. Genetics·Russell Schwartz, Alejandro A Schäffer
Nov 25, 2016·Scientific Reports·Youngjune ParkSun Kim
Feb 6, 2017·Cold Spring Harbor Perspectives in Medicine·Angelo FortunatoJohn W Pepper
Apr 25, 2017·Scientific Reports·Francisco Martínez-JiménezMarc A Marti-Renom
Feb 28, 2016·Biochimica Et Biophysica Acta·John R Packer, Norman J Maitland
May 5, 2017·International Journal of Cancer. Journal International Du Cancer·Peter UlzMichael R Speicher
May 20, 2017·Expert Review of Molecular Diagnostics·Marta Lionetti, Antonino Neri
May 16, 2017·Expert Review of Gastroenterology & Hepatology·Chelsie K SieversPerry J Pickhardt
May 20, 2017·Molecular Biology and Evolution·Yuxin ChenChung-I Wu
May 13, 2017·Briefings in Bioinformatics·Igor B RogozinDavid N Cooper
Feb 12, 2017·Cell·Nicholas McGranahan, Charles Swanton
Feb 1, 2017·Nature Communications·Johannes G ReiterMartin A Nowak
Mar 28, 2017·Scientific Reports·Benjamin WernerDavid Dingli
Aug 27, 2017·Virchows Archiv : an International Journal of Pathology·Asier ErramuzpeJosé I López
Jul 16, 2017·Cold Spring Harbor Perspectives in Medicine·Ruping SunChristina Curtis
May 17, 2018·Digestive Diseases and Sciences·William M Grady, Ming Yu
May 16, 2018·Proceedings of the National Academy of Sciences of the United States of America·Marc D RyserDarryl Shibata
Aug 31, 2017·Nature Genetics·Javad Noorbakhsh, Jeffrey H Chuang
Aug 31, 2017·Nature Genetics·Marc J WilliamsAndrea Sottoriva
Dec 14, 2017·Frontiers in Immunology·Mirjana EfremovaZlatko Trajanoski
May 12, 2017·Cold Spring Harbor Perspectives in Medicine·Kit CurtiusTrevor A Graham
Jan 4, 2018·Nature Communications·Mirjana EfremovaZlatko Trajanoski
Dec 29, 2017·BMC Evolutionary Biology·Tiffany B TaylorPhil Dash
Dec 2, 2017·International Journal of Cancer. Journal International Du Cancer·Alastair DroopLucy F Stead
Jun 19, 2018·PLoS Computational Biology·Nathaniel Mon PèreDavid Dingli
Aug 4, 2018·JAMA Ophthalmology·Eszter SzalaiHans E Grossniklaus
Sep 6, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jasmine A McQuerryAndrea H Bild
Oct 31, 2018·Nature Genetics·Timon HeideAndrea Sottoriva
Oct 31, 2018·Nature Genetics·Maxime TarabichiPeter Van Loo
Mar 15, 2016·F1000Research·Laura GayTrevor A Graham
Mar 1, 2018·Genome Medicine·Patricia C GalipeauXiaohong Li

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
exome-sequencing
chromosomal aberration

Software Mentioned

MSIsensor
Mutect
Julia
Sequenza
VarScan2

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

© 2022 Meta ULC. All rights reserved